US10385346B2 - Xylosidase having improved enzymatic activity - Google Patents

Xylosidase having improved enzymatic activity Download PDF

Info

Publication number
US10385346B2
US10385346B2 US16/157,692 US201816157692A US10385346B2 US 10385346 B2 US10385346 B2 US 10385346B2 US 201816157692 A US201816157692 A US 201816157692A US 10385346 B2 US10385346 B2 US 10385346B2
Authority
US
United States
Prior art keywords
xylosidase
amino acid
acid sequence
seq
enzymatic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US16/157,692
Other versions
US20190119687A1 (en
Inventor
Ya-Shan Cheng
Tzu-Hui Wu
Cheng-Yen Lin
Hui-Lin Lai
Cheng-Bin Zheng
Ting-Yung Huang
I-Hsuan LIN
Jian-Wen Huang
Chun-Chi Chen
Rey-Ting Guo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan APAC Biotechnology Co Ltd
Original Assignee
Dongguan APAC Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan APAC Biotechnology Co Ltd filed Critical Dongguan APAC Biotechnology Co Ltd
Assigned to Dongguan APAC Biotechnology Co., Ltd. reassignment Dongguan APAC Biotechnology Co., Ltd. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HUANG, JIAN-WEN, CHEN, CHUN-CHI, GUO, REY-TING, CHENG, YA-SHAN, HUANG, TING-YUNG, LAI, HUI-LIN, LIN, CHENG-YEN, LIN, I-HSUAN, WU, TZU-HUI, ZHENG, Cheng-bin
Publication of US20190119687A1 publication Critical patent/US20190119687A1/en
Application granted granted Critical
Publication of US10385346B2 publication Critical patent/US10385346B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01037—Xylan 1,4-beta-xylosidase (3.2.1.37)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01072—Xylan 1,3-beta-xylosidase (3.2.1.72)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01177—Alpha-D-xyloside xylohydrolase (3.2.1.177)

Definitions

  • the present invention relates to a xylosidase, and more particularly to a xylosidase having improved enzymatic activity.
  • Xylan is hemicellulose, which is the major component in plant cell wall, and also the second most abundant polysaccharides on earth. Therefore, the hydrolytic enzymes that degrade xylan are highly attractive and widely applied in many industries for a long time.
  • Xylan is a long chain polysaccharide, which is composed of many pentose xylose units linked by ⁇ -1,4-glycosidic bond as a backbone of xylan.
  • xylan is complex and highly branched heteropolysaccharide which can be decorated by methyl group or acetyl group, even branched by other sugar molecules to form various structures of xylan. Because of this complicated architecture of xylan, the complete degradation of xylan requires different xylanolytic enzymes to work together for decomposing xylan into simple sugars that can be used by organisms.
  • xylanolytic enzymes can be divided into several groups including endo- ⁇ -D-xylanase, ⁇ -1,4-xylosidase, arabinase, acetylxylan esterase and ⁇ -glucuronidase.
  • ⁇ -1,4-xylosidase (EC 3.2.1.37) is a crucial enzyme for complete degradation of xylan. It is an exoglucosidase that can hydrolyze the non-reducing ends of xylooligosaccharides into simple sugar xylose.
  • xylosidase works together with the endo-xylanase and other xylanolytic enzymes, these enzymes can be cooperatively used in many different industries, such as bleaching process in paper industry, dough quality and juice clearance in food industry, animal nutrition in feed industry, even in biofuel production. According to different industrial needs, xylosidase is required to be suitable for different appropriate working conditions. In addition to the protein properties of enzyme, its catalytic efficiency is also the key point for improving industrial enzyme. Higher enzymatic activity represents the cost reduction in the industrial process and further enhances the commercial profit.
  • xylosidase is modified by rational design to increase its enzymatic activity, so as to further increase its application potential and economic value in industry.
  • An object of the present invention is to modify a xylosidase by means of structural analysis and site-directed mutagenesis for improving the enzymatic activity of the xylosidase and further increasing its application potential and economic value in industry.
  • a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and a substitution of glutamine at position 41 with histidine.
  • the gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens .
  • the xylosidase has a full length amino acid sequence of SEQ ID NO: 10.
  • a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate.
  • the gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens .
  • the xylosidase has a full length amino acid sequence of SEQ ID NO: 6.
  • a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of glutamine at position 41 with histidine.
  • the gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens .
  • the xylosidase has a full length amino acid sequence of SEQ ID NO: 8.
  • FIG. 1 shows the nucleotide sequence and the amino acid sequence of the wild type xylosidase Hixy143A
  • FIG. 2 shows the mutagenic primer sequences for site-directed mutagenesis
  • FIG. 3 shows the nucleotide sequence and the amino acid sequence of the F35E mutant
  • FIG. 4 shows the nucleotide sequence and the amino acid sequence of the Q41H mutant
  • FIG. 5 shows the nucleotide sequence and the amino acid sequence of the F35E/Q41H mutant
  • FIG. 6 shows the enzymatic activity analysis of the wild type Hixy143A and the three mutants.
  • the xylosidase employed in the present invention is encoded by Hixy143A gene isolated from the themophilic fungus Humicola insolens Y1. According to previous studies, the optimal working condition of this xylosidase is at 50° C., pH 6.8.
  • the Hixy143A gene was cloned into a vector and transformed into Pichia pastoris for protein expression.
  • the present invention analyzed its protein structure and chose some potential amino acids for modifications by site-directed mutagenesis so as to improve the enzymatic activity of the xylosidase.
  • FIG. 1 shows the nucleotide sequence and the amino acid sequence of the wild type xylosidase Hixy143A, wherein the Hixy143A gene includes 978 base pairs (the nucleotide sequence was numbered as SEQ ID NO: 1) and encodes 326 amino acids (the amino acid sequence was numbered as SEQ ID NO: 2).
  • the Hixy143A gene was cloned into pPICZ ⁇ A vector by EcoRI and NotI.
  • the plasmid DNA was linearized by PmeI and then transformed into Pichia pastoris .
  • the transformants were selected by YPD plate with 0.1 mg/ml zeocin at 30° C. for 2 days.
  • the selected clones were individually inoculated in YPD medium at 30° C. overnight and then amplified in BMGY medium at 30° C. overnight. Finally, the amplified cells were transferred to BMMY medium containing 0.5% methanol to induce the protein expression. The supernatants with induced proteins were collected by centrifugation for following analysis.
  • the three mutated genes of Hixy143A were obtained by site-directed mutagenesis. Particularly, these mutated sequences were obtained by polymerase chain reaction method using the wild type Hixy143A gene as the template and using the mutagenic primers shown in FIG. 2 .
  • F35E means the phenylalanine at position 35 was substituted with glutamate, and the mutagenic primer F35E was numbered as SEQ ID NO: 3.
  • Q41H means the glutamine at position 41 was substituted with histidine, and the mutagenic primer Q41H was numbered as SEQ ID NO: 4. Therefore, the three mutated genes of Hixy143A obtained by site-directed mutagenesis in the present invention were F35E, Q41H and F35E/Q41H.
  • FIGS. 3 to 5 show the nucleotide sequences and the amino acid sequences of the three mutants.
  • FIG. 3 shows the nucleotide sequence and the amino acid sequence of the F35E mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 5, the amino acid sequence was numbered as SEQ ID NO: 6, and the phenylalanine at position 35 was substituted with glutamate.
  • FIG. 4 shows the nucleotide sequence and the amino acid sequence of the Q41H mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 7, the amino acid sequence was numbered as SEQ ID NO: 8, and the glutamine at position 41 was substituted with histidine.
  • FIG. 3 shows the nucleotide sequence and the amino acid sequence of the F35E mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 5, the amino acid sequence was numbered as SEQ ID NO: 6, and the phenylalanine at position 35 was substituted with glutamate.
  • FIG. 5 shows the nucleotide sequence and the amino acid sequence of the F35E/Q41H mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 9, the amino acid sequence was numbered as SEQ ID NO: 10, and the phenylalanine at position 35 was substituted with glutamate and the glutamine at position 41 was substituted with histidine.
  • the original DNA template was removed by DpnI at 37° C.
  • the three mutated genes were individually transformed into E. coli .
  • the success of gene mutation was confirmed by DNA sequencing.
  • the three successful mutated genes were separately transformed into P. pastoris and then induced for expressing the mutated proteins by the same method mentioned above. Afterwards, the wild type protein and the mutated proteins were further analyzed for their enzymatic activity.
  • the xylosidase activity analysis was determined by the measurement of released nitrophenol that is a chromogenic product from the hydrolysis of the substrate p-nitrophenyl- ⁇ -D-xylopyranoside by xylosidase and further calculated to determine the enzymatic activity of xylosidase.
  • the reaction mixture composed of diluted protein sample and 5 mM p-nitrophenyl- ⁇ -D-xylopyranoside was incubated at 50° C. for 10 min. The reaction was then stopped by using 2 M Na 2 CO 3 . Finally, the absorption of OD410 nm was detected to determine the activity of xylosidase.
  • FIG. 6 shows the enzymatic activity analysis of the wild type Hixy143A and the three mutants.
  • the single mutants F35E and Q41H both showed higher activities than did the wild type protein.
  • F35E mutant significantly increased the activity of nearly 90% while Q41H mutant increased the activity of about 20%.
  • the double mutant F35E/Q41H showed notably increased activity to about 250%, which is much higher than the wild type protein and the single mutants.
  • the protein expression levels of the mutants were similar to that of the wild type protein.
  • the present invention chose some potential amino acids according to its structural analysis and further modified this enzyme by rational design.
  • the three mutants including F35E, Q41H and F35E/Q41H all showed higher enzymatic activities compared to the wild type protein, and even had 2.5-fold increase. Therefore, the present invention successfully improves the enzymatic activity of the xylosidase and further increases its economic value of industrial application.
  • xylosidase can be mixed with feed to help the digestion and absorption of the monogastric animals like pig and chicken by degrading feed materials with hemicellulose.
  • the enzymes also can reduce or replace the traditional toxic chemical method to reach the same result of bleaching.
  • the enzymes provide assistances in the juice clearance and the saccharification step of brewing industry.
  • biofuel production xylosidase can degrade substrates to produce single sugars that can be utilized in fermentation by microorganisms.
  • xylosidase can be widely used in various industries and has high economic value.
  • the present invention modifies the xylosidase by genetic engineering, and the modified enzymes have significantly improved enzymatic activity, so the production cost of the xylosidase can be reduced to further improve the economic value of industrial application.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A xylosidase having improved enzymatic activity is disclosed. The amino acid sequence of the xylosidase is a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and/or a substitution of glutamine at position 41 with histidine.

Description

FIELD OF THE INVENTION
The present invention relates to a xylosidase, and more particularly to a xylosidase having improved enzymatic activity.
BACKGROUND OF THE INVENTION
Xylan is hemicellulose, which is the major component in plant cell wall, and also the second most abundant polysaccharides on earth. Therefore, the hydrolytic enzymes that degrade xylan are highly attractive and widely applied in many industries for a long time. Xylan is a long chain polysaccharide, which is composed of many pentose xylose units linked by β-1,4-glycosidic bond as a backbone of xylan. In nature, xylan is complex and highly branched heteropolysaccharide which can be decorated by methyl group or acetyl group, even branched by other sugar molecules to form various structures of xylan. Because of this complicated architecture of xylan, the complete degradation of xylan requires different xylanolytic enzymes to work together for decomposing xylan into simple sugars that can be used by organisms.
In general, xylanolytic enzymes can be divided into several groups including endo-β-D-xylanase, β-1,4-xylosidase, arabinase, acetylxylan esterase and α-glucuronidase. Among these enzymes, β-1,4-xylosidase (EC 3.2.1.37) is a crucial enzyme for complete degradation of xylan. It is an exoglucosidase that can hydrolyze the non-reducing ends of xylooligosaccharides into simple sugar xylose.
Since the xylosidase works together with the endo-xylanase and other xylanolytic enzymes, these enzymes can be cooperatively used in many different industries, such as bleaching process in paper industry, dough quality and juice clearance in food industry, animal nutrition in feed industry, even in biofuel production. According to different industrial needs, xylosidase is required to be suitable for different appropriate working conditions. In addition to the protein properties of enzyme, its catalytic efficiency is also the key point for improving industrial enzyme. Higher enzymatic activity represents the cost reduction in the industrial process and further enhances the commercial profit.
Currently, many researches try to obtain better enzymes by either screening in nature or modifying present enzymes. In the present invention, xylosidase is modified by rational design to increase its enzymatic activity, so as to further increase its application potential and economic value in industry.
SUMMARY OF THE INVENTION
An object of the present invention is to modify a xylosidase by means of structural analysis and site-directed mutagenesis for improving the enzymatic activity of the xylosidase and further increasing its application potential and economic value in industry.
According to an aspect of the present invention, there is provided a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and a substitution of glutamine at position 41 with histidine. The gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens. The xylosidase has a full length amino acid sequence of SEQ ID NO: 10.
According to another aspect of the present invention, there is provided a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate. The gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens. The xylosidase has a full length amino acid sequence of SEQ ID NO: 6.
According to an additional aspect of the present invention, there is provided a xylosidase comprising a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of glutamine at position 41 with histidine. The gene encoding the amino acid sequence of SEQ ID NO: 2 is Hixy143A gene isolated from Humicola insolens. The xylosidase has a full length amino acid sequence of SEQ ID NO: 8.
The above objects and advantages of the present invention will become more readily apparent to those ordinarily skilled in the art after reviewing the following detailed description and accompanying drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows the nucleotide sequence and the amino acid sequence of the wild type xylosidase Hixy143A;
FIG. 2 shows the mutagenic primer sequences for site-directed mutagenesis;
FIG. 3 shows the nucleotide sequence and the amino acid sequence of the F35E mutant;
FIG. 4 shows the nucleotide sequence and the amino acid sequence of the Q41H mutant;
FIG. 5 shows the nucleotide sequence and the amino acid sequence of the F35E/Q41H mutant; and
FIG. 6 shows the enzymatic activity analysis of the wild type Hixy143A and the three mutants.
 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The present invention will now be described more specifically with reference to the following embodiments. It is to be noted that the following descriptions of preferred embodiments of this invention are presented herein for purpose of illustration and description only; it is not intended to be exhaustive or to be limited to the precise form disclosed.
The xylosidase employed in the present invention is encoded by Hixy143A gene isolated from the themophilic fungus Humicola insolens Y1. According to previous studies, the optimal working condition of this xylosidase is at 50° C., pH 6.8. In the present invention, the Hixy143A gene was cloned into a vector and transformed into Pichia pastoris for protein expression. For improving the industrial application value of this xylosidase, the present invention analyzed its protein structure and chose some potential amino acids for modifications by site-directed mutagenesis so as to improve the enzymatic activity of the xylosidase. Based on the structural analysis, Phe35 and Gln41, which are both located in the active site of the xylosidase, were chosen for further modifications. By site-directed mutagenesis, Phe35 was singly mutated to glutamate as F35E mutant, while Gln41 was singly mutated to histidine as Q41H mutant. These two mutation sites were even combined into F35E/Q41H double mutant. The above mutations all successfully improved the enzymatic activity of the xylosidase.
The enzyme modification processes and the resulted xylosidase are described in detail as follows.
FIG. 1 shows the nucleotide sequence and the amino acid sequence of the wild type xylosidase Hixy143A, wherein the Hixy143A gene includes 978 base pairs (the nucleotide sequence was numbered as SEQ ID NO: 1) and encodes 326 amino acids (the amino acid sequence was numbered as SEQ ID NO: 2). First, the Hixy143A gene was cloned into pPICZαA vector by EcoRI and NotI. The plasmid DNA was linearized by PmeI and then transformed into Pichia pastoris. The transformants were selected by YPD plate with 0.1 mg/ml zeocin at 30° C. for 2 days. The selected clones were individually inoculated in YPD medium at 30° C. overnight and then amplified in BMGY medium at 30° C. overnight. Finally, the amplified cells were transferred to BMMY medium containing 0.5% methanol to induce the protein expression. The supernatants with induced proteins were collected by centrifugation for following analysis.
The three mutated genes of Hixy143A were obtained by site-directed mutagenesis. Particularly, these mutated sequences were obtained by polymerase chain reaction method using the wild type Hixy143A gene as the template and using the mutagenic primers shown in FIG. 2. F35E means the phenylalanine at position 35 was substituted with glutamate, and the mutagenic primer F35E was numbered as SEQ ID NO: 3. Q41H means the glutamine at position 41 was substituted with histidine, and the mutagenic primer Q41H was numbered as SEQ ID NO: 4. Therefore, the three mutated genes of Hixy143A obtained by site-directed mutagenesis in the present invention were F35E, Q41H and F35E/Q41H.
FIGS. 3 to 5 show the nucleotide sequences and the amino acid sequences of the three mutants. FIG. 3 shows the nucleotide sequence and the amino acid sequence of the F35E mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 5, the amino acid sequence was numbered as SEQ ID NO: 6, and the phenylalanine at position 35 was substituted with glutamate. FIG. 4 shows the nucleotide sequence and the amino acid sequence of the Q41H mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 7, the amino acid sequence was numbered as SEQ ID NO: 8, and the glutamine at position 41 was substituted with histidine. FIG. 5 shows the nucleotide sequence and the amino acid sequence of the F35E/Q41H mutant, wherein the nucleotide sequence was numbered as SEQ ID NO: 9, the amino acid sequence was numbered as SEQ ID NO: 10, and the phenylalanine at position 35 was substituted with glutamate and the glutamine at position 41 was substituted with histidine.
The original DNA template was removed by DpnI at 37° C. The three mutated genes were individually transformed into E. coli. The success of gene mutation was confirmed by DNA sequencing. Finally, the three successful mutated genes were separately transformed into P. pastoris and then induced for expressing the mutated proteins by the same method mentioned above. Afterwards, the wild type protein and the mutated proteins were further analyzed for their enzymatic activity.
The xylosidase activity analysis was determined by the measurement of released nitrophenol that is a chromogenic product from the hydrolysis of the substrate p-nitrophenyl-β-D-xylopyranoside by xylosidase and further calculated to determine the enzymatic activity of xylosidase. Basically, the reaction mixture composed of diluted protein sample and 5 mM p-nitrophenyl-β-D-xylopyranoside was incubated at 50° C. for 10 min. The reaction was then stopped by using 2 M Na2CO3. Finally, the absorption of OD410 nm was detected to determine the activity of xylosidase.
FIG. 6 shows the enzymatic activity analysis of the wild type Hixy143A and the three mutants. As shown in FIG. 6, under the same protein concentrations of these proteins, the single mutants F35E and Q41H both showed higher activities than did the wild type protein. When compared to the wild type protein, F35E mutant significantly increased the activity of nearly 90% while Q41H mutant increased the activity of about 20%. The double mutant F35E/Q41H showed notably increased activity to about 250%, which is much higher than the wild type protein and the single mutants. Besides, the protein expression levels of the mutants were similar to that of the wild type protein. Therefore, the total activities of these mutants F35E, Q41H and F35E/Q41H were also higher than that of the wild type protein, and the double mutant F35E/Q41H had the highest activity. It is clear that the three mutants provided in the present invention all have higher activities when compared to the wild type protein Hixy143A, that means the production cost of the xylosidase can be reduced, and thus the mutants have higher economic value of industrial application.
In conclusion, to improve the enzymatic activity of the xylosidase Hixy143A, the present invention chose some potential amino acids according to its structural analysis and further modified this enzyme by rational design. As a result, the three mutants including F35E, Q41H and F35E/Q41H all showed higher enzymatic activities compared to the wild type protein, and even had 2.5-fold increase. Therefore, the present invention successfully improves the enzymatic activity of the xylosidase and further increases its economic value of industrial application.
Nowadays, the application fields of the xylosidase and its related xylanase in industry are widespread. For feed industry, xylanolytic enzymes can be mixed with feed to help the digestion and absorption of the monogastric animals like pig and chicken by degrading feed materials with hemicellulose. As for paper and pulp industry, the enzymes also can reduce or replace the traditional toxic chemical method to reach the same result of bleaching. Besides, the enzymes provide assistances in the juice clearance and the saccharification step of brewing industry. As for biofuel production, xylosidase can degrade substrates to produce single sugars that can be utilized in fermentation by microorganisms. Thus, xylosidase can be widely used in various industries and has high economic value. The present invention modifies the xylosidase by genetic engineering, and the modified enzymes have significantly improved enzymatic activity, so the production cost of the xylosidase can be reduced to further improve the economic value of industrial application.
While the invention has been described in terms of what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention needs not be limited to the disclosed embodiment. On the contrary, it is intended to cover various modifications and similar arrangements included within the spirit and scope of the appended claims which are to be accorded with the broadest interpretation so as to encompass all such modifications and similar structures.

Claims (3)

What is claimed is:
1. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate, and a substitution of glutamine at position 41 with histidine.
2. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of phenylalanine at position 35 with glutamate.
3. A xylosidase consisting of a modified amino acid sequence of SEQ ID NO: 2, wherein the modification is a substitution of glutamine at position 41 with histidine.
US16/157,692 2017-10-25 2018-10-11 Xylosidase having improved enzymatic activity Expired - Fee Related US10385346B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TW106136658 2017-10-25
TW106136658A 2017-10-25
TW106136658A TWI626312B (en) 2017-10-25 2017-10-25 Xylosidase having improved enzymatic activity

Publications (2)

Publication Number Publication Date
US20190119687A1 US20190119687A1 (en) 2019-04-25
US10385346B2 true US10385346B2 (en) 2019-08-20

Family

ID=63256074

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/157,692 Expired - Fee Related US10385346B2 (en) 2017-10-25 2018-10-11 Xylosidase having improved enzymatic activity

Country Status (2)

Country Link
US (1) US10385346B2 (en)
TW (1) TWI626312B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110699339B (en) * 2019-09-16 2021-12-28 天津科技大学 Low-temperature beta-xylosidase mutant with improved thermal stability and specific activity and coding gene and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130183713A1 (en) * 2010-08-30 2013-07-18 Novoyzmes A/S Polypeptides Having Beta-Glucosidase Activity, Beta-Xylosidase Activity, or Beta-Glucosidase Activity and Beta-Xylosidase Activity And Polynucleotides Encoding Same
US20140017733A1 (en) * 2012-06-11 2014-01-16 Codexis, Inc. Fungal xylanases and xylosidases
US8722382B1 (en) * 2013-04-17 2014-05-13 Dongguan APAC Biotechnology Co., Ltd. Xylanase having improved enzymatic activity
US20140273119A1 (en) * 2011-12-01 2014-09-18 Novozymes Inc. Polypeptides Having Beta-Xylosidase Activity and Polynucleotides Encoding Same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3330375A1 (en) * 2015-07-29 2018-06-06 Abengoa Bioenergía Nuevas Tecnologías, S. A. Expression of recombinant beta-xylosidase enzymes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130183713A1 (en) * 2010-08-30 2013-07-18 Novoyzmes A/S Polypeptides Having Beta-Glucosidase Activity, Beta-Xylosidase Activity, or Beta-Glucosidase Activity and Beta-Xylosidase Activity And Polynucleotides Encoding Same
US20140273119A1 (en) * 2011-12-01 2014-09-18 Novozymes Inc. Polypeptides Having Beta-Xylosidase Activity and Polynucleotides Encoding Same
US20140017733A1 (en) * 2012-06-11 2014-01-16 Codexis, Inc. Fungal xylanases and xylosidases
US8722382B1 (en) * 2013-04-17 2014-05-13 Dongguan APAC Biotechnology Co., Ltd. Xylanase having improved enzymatic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PIR Accession No. S55893, published Mar. 19, 1997 (Year: 1997). *

Also Published As

Publication number Publication date
TW201917212A (en) 2019-05-01
TWI626312B (en) 2018-06-11
US20190119687A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
Favaro et al. Consolidated bioprocessing of starchy substrates into ethanol by industrial Saccharomyces cerevisiae strains secreting fungal amylases
Basit et al. Xylanase and its industrial applications
Nghi et al. The wood rot ascomycete Xylaria polymorpha produces a novel GH78 glycoside hydrolase that exhibits α-L-rhamnosidase and feruloyl esterase activities and releases hydroxycinnamic acids from lignocelluloses
Ye et al. Production and characteristics of a novel xylose-and alkali-tolerant GH 43 β-xylosidase from Penicillium oxalicum for promoting hemicellulose degradation
CN103275955B (en) Xylosidase Xyl43B with high xylose tolerance, and gene and application thereof
MX2011002142A (en) Modified beta-glucosidases with improved stability.
Zheng et al. An endoxylanase rapidly hydrolyzes xylan into major product xylobiose via transglycosylation of xylose to xylotriose or xylotetraose
Kislitsin et al. The effect of cellobiohydrolase 1 gene knockout for composition and hydrolytic activity of the enzyme complex secreted by filamentous fungus Penicillium verruculosum
Squina et al. Xylan decomposition by Aspergillus clavatus endo-xylanase
de Lima Damásio et al. Heterologous expression of an Aspergillus niveus xylanase GH11 in Aspergillus nidulans and its characterization and application
Li et al. Expression of an AT-rich xylanase gene from the anaerobic fungus Orpinomyces sp. strain PC-2 in and secretion of the heterologous enzyme by Hypocrea jecorina
Yang et al. Codon-optimized expression and characterization of a pH stable fungal xylanase in Pichia pastoris
EP3000880A1 (en) Expression of recombinant beta-xylosidase enzymes
Zheng et al. Transformation of corncob into high-value xylooligosaccharides using glycoside hydrolase families 10 and 11 xylanases from Trichoderma asperellum ND-1
Huy et al. Cloning and characterization of a thermostable endo-arabinanase from Phanerochaete chrysosporium and its synergistic action with endo-xylanase
US10385346B2 (en) Xylosidase having improved enzymatic activity
MX2011000552A (en) Modified family 6 glycosidases with altered substrate specificity.
Wen et al. Highly efficient synergistic activity of an α-L-arabinofuranosidase for degradation of arabinoxylan in barley/wheat
US20210171993A1 (en) Polysaccharide-oxidizing composition and uses thereof
US8722382B1 (en) Xylanase having improved enzymatic activity
CN108884481A (en) β-glucosyl enzym and application thereof
US8865444B1 (en) β-mannanase having improved enzymatic activity
CN108368530A (en) β-glucosyl enzym and application thereof
Zhuang et al. Efficacious bioconversion of alginate/cellulose to value-added oligosaccharides by alginate-degrading GH5 endoglucanase from Trichoderma asperellum
Min et al. Statistical optimization of medium components for the production of xylanase by Aspergillus niger KK2 in submerged cultivation

Legal Events

Date Code Title Description
AS Assignment

Owner name: DONGGUAN APAC BIOTECHNOLOGY CO., LTD., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHENG, YA-SHAN;WU, TZU-HUI;LIN, CHENG-YEN;AND OTHERS;SIGNING DATES FROM 20180920 TO 20181010;REEL/FRAME:047136/0959

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20230820